Atlas Trials

Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics

Clinical trial NCT02596880 · COMPLETED

Trial details

NCT number
NCT02596880
Sponsor
Tehran University of Medical Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis CCirrhosis
Start date
2015-09-01
Primary completion
2016-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.